|
DERL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94150000000826E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.049880E-04 |
| Normal-vs-Stage2 |
8.849800E-02 |
| Normal-vs-Stage3 |
1.370770E-01 |
| Normal-vs-Stage4 |
9.613000E-01 |
| Stage1-vs-Stage2 |
8.013800E-01 |
| Stage1-vs-Stage3 |
8.190600E-01 |
| Stage1-vs-Stage4 |
1.253000E-01 |
| Stage2-vs-Stage3 |
9.877200E-01 |
| Stage2-vs-Stage4 |
2.824400E-01 |
| Stage3-vs-Stage4 |
3.874000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7249000000017E-05 |
| Normal-vs-AfricanAmerican |
3.602200E-02 |
| Normal-vs-Asian |
2.033800E-01 |
| Caucasian-vs-AfricanAmerican |
2.056600E-01 |
| Caucasian-vs-Asian |
4.860200E-01 |
| AfricanAmerican-vs-Asian |
3.599200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.646820E-04 |
| Normal-vs-Female |
2.715900E-03 |
| Male-vs-Female |
7.620200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.025500E-02 |
| Normal-vs-Extreme_Weight |
4.221200E-04 |
| Normal-vs-Obese |
2.000100E-02 |
| Normal-vs-Extreme_Obese |
2.809600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.077200E-01 |
| Normal_Weight-vs-Obese |
8.817800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.638000E-01 |
| Extreme_Weight-vs-Obese |
4.227400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.906600E-01 |
| Obese-vs-Extreme_Obese |
9.144000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.990350E-02 |
| Normal-vs-Age(41-60Yrs) |
3.38509999997516E-06 |
| Normal-vs-Age(61-80Yrs) |
4.784300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.742200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.466800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.506400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.247500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.564200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.393650E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.491600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.84999998548352E-09 |
| Normal-VS-Type2 PRCC |
5.504000E-01 |
| Normal-VS-KIRP CIMP |
7.992400E-01 |
| Normal-VS-Unclassified PRCC |
1.683160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.357920E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.301510E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.794200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.960600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.137400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.138000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.149650E-01 |
| Normal-vs-N1 |
7.486400E-02 |
| Normal-vs-N2 |
1.557010E-01 |
| N0-vs-N1 |
3.672000E-01 |
| N0-vs-N2 |
2.151600E-01 |
| N1-vs-N2 |
1.922550E-01 |
|
|
